CASI Pharmaceuticals, Inc (DE) Quarterly Costs and Expenses in USD from Q2 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Costs and Expenses for the quarter ending December 31, 2022 was $23.6M, a 44% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Costs and Expenses for the twelve months ending December 31, 2022 was $61.3M, a 3.7% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2022 was $61.3M, a 3.7% increase from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2021 was $59.1M, a 1.22% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2020 was $58.4M, a 14.3% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $61.3M $23.6M +$7.22M +44% Oct 1, 2022 Dec 31, 2022 20-F 2023-04-26
Q3 2022 $54.1M $12.3M +$733K +6.33% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $53.4M $12.8M +$611K +5.03% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $52.7M $12.6M -$6.38M -33.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $59.1M $16.4M +$2.8M +20.6% Oct 1, 2021 Dec 31, 2021 20-F 2023-04-26
Q3 2021 $56.3M $11.6M -$9.49M -45% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $65.8M $12.2M +$600K +5.19% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $65.2M $19M +$6.8M +55.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $58.4M $13.6M +$80K +0.59% Oct 1, 2020 Dec 31, 2020 20-F 2023-04-26
Q3 2020 $58.3M $21.1M +$7.65M +56.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $50.7M $11.6M -$4.25M -26.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $54.9M $12.2M +$3.85M +46.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $51.1M $13.5M +$4.5M +49.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $46.6M $13.4M +$4.72M +54.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $41.9M $15.8M +$10M +174% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $31.8M $8.33M +$4.64M +126% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $27.2M $9.02M +$3.98M +78.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $23.2M $8.71M +$7.11M +446% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $16.1M $5.77M +$3.35M +139% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $12.7M $3.69M +$1.99M +118% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $10.8M $5.04M +$2.37M +89% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $8.38M $1.6M -$94K -5.56% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $8.47M $2.42M -$859K -26.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $9.33M $1.69M -$90.4K -5.07% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $9.42M $2.67M +$964K +56.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $8.46M $1.69M +$74.6K +4.62% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $8.38M $3.28M +$1.19M +57.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $7.19M $1.78M -$12.2K -0.68% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $7.2M $1.7M +$89.6K +5.55% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $7.11M $1.62M -$19.9M -92.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $27M $2.08M +$467K +28.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $26.6M $1.8M +$345K +23.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $26.2M $1.61M +$306K +23.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 $25.9M $21.5M +$20.1M +1392% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $5.82M $1.62M -$236K -12.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $6.06M $1.45M +$315K +27.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $5.74M $1.31M +$279K +27.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 $5.46M $1.44M +$255K +21.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $5.21M $1.85M +$554K +42.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $4.65M $1.14M -$522K -31.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $5.17M $1.03M +$102K +11% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-21
Q3 2012 $5.07M $1.19M -$72.3K -5.74% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $5.14M $1.3M -$372K -22.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $5.52M $1.66M -$993K -37.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $6.51M $928K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-21
Q3 2011 $1.26M -$723K -36.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $1.67M -$3.11M -65.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $2.65M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $1.98M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $4.78M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.